Transcription of FUND FACTSHEET Omnis US Equity Fund
{{id}} {{{paragraph}}}
Example: dental hygienist
FUND FACTSHEET Omnis US Equity Fund
fund FACTSHEET Omnis US Equity fund April 2018 Investment Manager Market Review Investment T. Rowe Price International Manager Ltd Quarter 1, 2018. Sub-Delegated to x ABOUT THE fund MANAGER. T. Rowe Price Associates During the period, stock selection drove relative outperformance while sector allocation was negative and the fund fell in Jeff Rottinghaus has 14 years of investment experience, 13. Investment The aim is to achieve capital total return terms. Stock selection in healthcare was the largest contributor to relative returns, led by positions in Danaher of which have been with T. Rowe Price. Prior to joining the Objective growth and Thermo Fisher Scientific. Within financials, security choices also aided relative gains, led by insurer XL Group.
FUND FACTSHEET April 2018 Investment Manager Market Review During the period, stock selection drove relative outperformance while sector allocation was negative and the fund fell in
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: